{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:03:05Z","timestamp":1780578185435,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtha.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:52:01Z","timestamp":1772610721000},"page":"2273-2292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acetylsalicylic acid improves outcome after acute myocardial infarction by reducing thromboinflammation"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-2239","authenticated-orcid":false,"given":"Carolin","family":"Helten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Benkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Metzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Barcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Haurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Alde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Duse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Levkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ommer-Blaesius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Dannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-9672","authenticated-orcid":false,"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ehjqcco\/qcac014","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021: executive summary","volume":"8","author":"Timmis","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jtha.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000517994","article-title":"V. loading during elective percutaneous coronary intervention","volume":"106","author":"Naguib","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.jtha.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000442706","article-title":"Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR Study)","volume":"134","author":"Lemesle","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.jtha.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamacardio.2024.0534","article-title":"Extended clopidogrel monotherapy vs DAPT in patients with acute coronary syndromes at high ischemic and bleeding risk: the OPT-BIRISK randomized clinical trial","volume":"9","author":"Li","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00228-018-2560-z","article-title":"Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients","volume":"75","author":"Dannenberg","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2026.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022299","article-title":"Excess mortality in aspirin and dipyrone (metamizole) co-medicated in patients with cardiovascular disease: a nationwide study","volume":"10","author":"Polzin","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.02.003_bib22","article-title":"Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention","volume":"38","author":"M\u2019Pembele","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11239-019-01983-x","article-title":"Platelet reactivity in patients with chronic kidney disease and hemodialysis","volume":"49","author":"Mourikis","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.02.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107592","article-title":"Lipid lowering therapy in cardiovascular disease: from myth to molecular reality","volume":"213","author":"Mourikis","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jtha.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jth.13997","article-title":"Platelet function testing: dead or alive","volume":"16","author":"Helten","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/FJC.0000000000000631","article-title":"Platelet reactivity in patients on aspirin and clopidogrel therapy measured by a new bedside whole-blood assay","volume":"73","author":"Polzin","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jtha.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0300985810364389","article-title":"Pathophysiology of cyclooxygenases in cardiovascular homeostasis","volume":"47","author":"Sellers","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jtha.2026.02.003_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx502.P1781","article-title":"Inhibition of chronic inflammation by low-dose aspirin medication","volume":"38","author":"Poehl","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1182\/bloodadvances.2024014273","article-title":"Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction","volume":"8","author":"Benkhoff","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.003_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23190","article-title":"Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke","volume":"34","author":"Lim","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jtha.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/cells9010231","article-title":"Neutrophil extracellular traps and cardiovascular diseases: an update","volume":"9","author":"Bonaventura","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation","volume":"92","author":"Inwald","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.thromres.2007.12.019","article-title":"Neutrophil CD40 enhances platelet-mediated inflammation","volume":"122","author":"Vanichakarn","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"102","author":"Lievens","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/ATVBAHA.115.307074","article-title":"Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes","volume":"36","author":"Gerdes","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.02.003_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134599","article-title":"Soluble CD40 ligand in aspirin-treated patients undergoing cardiac catheterization","volume":"10","author":"Gremmel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.02.003_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013396","article-title":"Aspirin reduces the potentiating effect of CD40L on platelet aggregation via inhibition of myosin light chain","volume":"9","author":"Kojok","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","article-title":"Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond","volume":"141","author":"Karnell","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtha.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/CS20220182","article-title":"Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage","volume":"136","author":"Mirabito Colafella","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jtha.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/cells11213500","article-title":"Only acute but not chronic thrombocytopenia protects mice against left ventricular dysfunction after acute myocardial infarction","volume":"11","author":"Reusswig","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-023-38069-5","article-title":"Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction","volume":"14","author":"Polzin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.02.003_bib47","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41467-021-23909-z","article-title":"Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease","volume":"12","author":"Lacy","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtha.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12872-023-03210-1","article-title":"SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction","volume":"23","author":"B\u00f6nner","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jtha.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(24)00473-2","article-title":"Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial","volume":"403","author":"Ge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2019.01731","article-title":"Platelets and immune responses during thromboinflammation","volume":"10","author":"Mezger","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"H1043","DOI":"10.1152\/ajpheart.00134.2018","article-title":"Do platelets promote cardiac recovery after myocardial infarction: roles beyond occlusive ischemic damage","volume":"314","author":"Walsh","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH14-11-0943","article-title":"Aspirin and P2Y12 inhibitors in platelet-mediated activation of neutrophils and monocytes","volume":"114","author":"Schrottmaier","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.smim.2016.10.013","article-title":"Role of platelets in neutrophil extracellular trap (NET) production and tissue injury","volume":"28","author":"Kim","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jtha.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1160\/TH14-05-0455","article-title":"Neutrophil extracellular traps (NETs) and the role of platelets in infection","volume":"112","author":"Andrews","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","article-title":"Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state","volume":"33","author":"Borissoff","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52671-y","article-title":"Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients","volume":"9","author":"Mangold","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2026.02.003_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7816491","article-title":"Neutrophil extracellular trap components associate with infarct size, ventricular function, and clinical outcome in STEMI","volume":"2019","author":"Helseth","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jtha.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcm.2007.02.004","article-title":"CD40 and its ligand in atherosclerosis","volume":"17","author":"Lutgens","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0735-1097(97)00116-2","article-title":"Induction of cytokine expression in leukocytes in acute myocardial infarction","volume":"30","author":"Marx","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.02.003_bib64","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.02.003_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trsl.2016.04.005","article-title":"Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes","volume":"176","author":"Napole\u00e3o","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jtha.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MCA.0000000000000142","article-title":"Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"25","author":"Pusuroglu","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jtha.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1515\/cclm-2021-0817","article-title":"Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"60","author":"Angeli","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.003_bib70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/ehi132","article-title":"Soluble CD40 ligand in acute and chronic heart failure","volume":"26","author":"Ueland","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.13901","article-title":"The role of platelet-neutrophil interactions in driving autoimmune diseases","volume":"175","author":"Liu","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.jtha.2026.02.003_bib72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0037-1615227","article-title":"Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions","volume":"80","author":"Kuijper","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.118.036323","article-title":"Platelet protein disulfide isomerase promotes glycoprotein Ib\u03b1-mediated platelet-neutrophil interactions under thromboinflammatory conditions","volume":"139","author":"Li","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.02.003_bib74","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1172\/JCI119742","article-title":"Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor","volume":"100","author":"Weber","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.02.003_bib75","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53353","article-title":"Activated \u03b1IIb\u03b23 on platelets mediates flow-dependent NETosis via SLC44A2","volume":"9","author":"Constantinescu-Bercu","year":"2020","journal-title":"eLife"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:05:08Z","timestamp":1780574708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1538783626001194"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylsalicylic acid improves outcome after acute myocardial infarction by reducing thromboinflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}